Out of curiosity, while as a newer investoro I've never seen the stock above $1, but clearly know it's been there, the stock charts say where it's been. What I don't know is the greatest market cap the company has ever had. Does anyone know what that value is.
I believe that once the top line data has been revealed, if it's as good as most hear think it will be, the market cap should go into new all time highs. I certainly think a market cap over $1 billion is possible, but it may not come immediately. Should a partnership occur before approval, it could go to multi billions almost immediately, as should occur with approval. I anticipate approval next year, hopefully in the first half of the year.
It actually could be more important to watch what happens in the trial of DCVax-Direct once that gets underway. If the data suggests a positive outcome in numerous cancers, I don't know that there is a practical limit on how high the market cap of NWBO could go if it remains independently trading.
It's very possible for a partnership offering to come in that essentially gives a partner control of the company, while it continues to trade independently. Roche has done this several times, purchasing say 30% of a company, in making a partnership. 30% normally is sufficient to give control, as it's almost impossible to defeat someone who owns 30% in a move requiring a shareholder vote. In the case of Roche and Genentech, they first bought a percentage, then on a vote acquired the company, then spun them off again, maintaining a controlling percentage, then bought them out again. Shareholders did well in all the manipulation, Roche probably did even better, and Genentech could be spun off again at any time Roche cared to do it.
I'd rather NWBO be partnered, and not acquired, especially if DCVax-Direct works in many cancers, and of course DCVax-L may also be tested in many others, probably not until it's been approved for GBM.
Gary
